Schizophrenia: risperidone and olanzapine increase time to discontinuation compared with quetiapine and ziprasidone

Affiliations

Comment

William T Carpenter. Evid Based Ment Health. 2006 Nov.

. 2006 Nov;9(4):106.

doi: 10.1136/ebmh.9.4.106.

¹ University of Maryland School of Medicine and Director, Maryland Psychiatric Research Center, Baltimore, Maryland, USA.

No abstract available

Comment on

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.
Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK; CATIE Investigators. Stroup TS, et al. Am J Psychiatry. 2006 Apr;163(4):611-22. doi: 10.1176/ajp.2006.163.4.611. Am J Psychiatry. 2006. PMID: 16585435 Clinical Trial.